Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2014

Oct 14, 2014

65058_rns_2014-10-14_c85aec04-b367-4398-8758-92b226d208dc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PRIMARY HEALTH CARE LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Edmund Gregory Thomas Bateman
Date of last notice 10 October 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest As shown
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving
rise to the relevant interest.
Not applicable
Dates of changes a) 10 October 2014
b) 13 October 2014
No. of securities held prior to
change
406,483
Abtourk (Syd No.391) Pty Ltd
17,413,251
Idameneo (No. 122) Pty Ltd
104,836
Belinda Carwardine Bateman and
Edmund Gregory Thomas Bateman
120,000
Belinda Carwardine Bateman
256,258 Dr Edmund Bateman
18,300,828
Ordinary shares
Class Fully paid ordinary shares
Number acquired 530,000
Number disposed Not applicable
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details
and estimated valuation
a) 30,000 at $4.22 per share
a) 100,000 at $4.25 per share
b) 400,000 at $4.13 per share
No. of securities held after
change
406,483
Abtourk (Syd No.391) Pty Ltd
17,413,251
Idameneo (No. 122) Pty Ltd
104,836
Belinda Carwardine Bateman and
Edmund Gregory Thomas Bateman
150,000
Belinda Carwardine Bateman
756,258 Dr Edmund Bateman
18,830,828
Ordinary shares
Nature of change
Example:
on-market
trade,
off-market
trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in buy-
back
On-market trades

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest Not applicable
Name of registered holder
(if issued securities)
Not applicable
Date of change Not applicable
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Not applicable
Interest acquired Not applicable
Interest disposed Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Not applicable
Interest after change Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts Not applicable detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the Not applicable trade to proceed during this period? If prior written clearance was provided, on what date Not applicable was this provided?

YD CACHIA Company Secretary Date: 15 October 2014

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011